Implantable Devices And Methods For The Evaluation of Active Agents

Abstract

Devices for the local delivery of microdose amounts of one or more active agents, alone or in combination, in one or more dosages, to selected tissue of a patient are described. The devices generally include multiple microwells arranged on or within a support structure. The microwells contain one or more active agents, alone or in combination, in one or more dosages and/or release pharmacokinetics. In an exemplary embodiment, the device has a cylindrical shape, having symmetrical wells on the outside of the device, each well containing one or more drugs, at one or more concentrations, sized to permit placement using a catheter, cannula, or stylet. Optionally, the device has a guidewire, and fiber optics, sensors and/or interactive features such as remote accessibility (such as WiFi) to provide for in situ retrieval of information and modification of device release properties. In the most preferred embodiment, the fiber optics and/or sensors are individually accessible to discrete wells.

We claim: 
     
         1 . An implantable microdevice comprising
 a support structure having on the surface thereof a plurality of microwells formed on or within the support structure,   the device having dimensions that permit implantation into a tissue using a catheter, cannula, or biopsy needle,   optionally comprising a guidewire attached to a proximal end of the device, one or more sensors integrated within the device or microwells, and fiber optic or other addressible or interactive means for remote interrogation of the device.   
     
     
         2 . The microdevice of  claim 1  comprising one or more active agents within the microwells. 
     
     
         3 . The microdevice of  claim 2  comprising a plurality of active agents, combinations of active agents or active agents with plurality of concentrations or release pharmacokinetics thereof. 
     
     
         4 . The microdevice of  claim 1 , wherein the device is cylindrical in shape and having a diameter of between about 0.5 mm and about 2.0 mm, and a length of less than about 5.0 mm. 
     
     
         5 . The microdevice of  claim 1  formed by a method selected from the group consisting of lithographic galvanoforming abforming (LIGA), high-aspect-ratio photolithography using a photoresist, microelectro-discharge machining, high-aspect-ratio machining by deep reactive ion etching (DIRE), hot embossing, 3-dimensional printing, stereolithography, laser machining, ion beam machining, and mechanical micro-cutting. 
     
     
         6 . The microdevice of  claim 1  comprising a guidewire attached to an end of the device, one or more sensors integrated within the device or microwells, and fiber optic or other addressible or interactive means for remote interrogation of the device. 
     
     
         7 . The microdevice of  claim 1  comprising means for maintaining tissue in a spatial orientation to the microdevice at the time of or after removal of the device. 
     
     
         8 . A kit comprising the microdevice of any of  claim 1  and means for insertion or means for removal. 
     
     
         9 . The kit of  claim 8 , wherein the microdevice comprises one or more active agents within the microwells. 
     
     
         10 . The kit of  claim 9 , wherein the microdevice comprises a plurality of active agents, combinations of active agents or active agents with plurality of concentrations or release pharmacokinetics thereof. 
     
     
         11 . The kit of  claim 8 , wherein the microdevice comprises a guidewire attached to an end of the device, one or more sensors integrated within the device or microwells, and fiber optic or other addressible or interactive means for remote interrogation of the microdevice. 
     
     
         12 . The kit of  claim 8 , wherein the microdevice comprises means for maintaining tissue in a spatial orientation to the microdevice at the time of or after removal of the microdevice. 
     
     
         13 . The kit of  claim 8  wherein the means for insertion is a biopsy cutting needle between 19 and 24 gauge. 
     
     
         14 . The kit of  claim 8  wherein the means for removal is a biopsy coring needle between 16 and 18 gauge. 
     
     
         15 . The kit of  claim 8  wherein the device comprises a guidewire attached to an end of the device, one or more sensors integrated within the device or microwells, and fiber optic or other addressible or interactive means for remote interrogation of the device, comprising means for interacting or receiving signals from the microdevice. 
     
     
         16 . A method for assaying tissue for an effective active agent, effective dosage, effective pharmacokinetics of an active agent, or a combination thereof, comprising implanting in a tissue the microdevice of  claim 1  and assaying for at least one analyte or removing tissue for analysis. 
     
     
         17 . The method of  claim 16  comprising removing the microdevice and adjacent tissue and analyzing the tissue. 
     
     
         18 . The method of  claim 16  wherein the tissue is a tumor. 
     
     
         19 . The method of  claim 16  wherein the tissue is infected or in need of immunomodulation or hormonal treatment.